Towards MXenes’ biomedical applications by high-dimensional immune MAPping (MX-MAP)

Project title: Towards MXenes’ biomedical applications by high-dimensional immune MAPping (MX-MAP)
Project contract number: 101086184 - HORIZON-MSCA-2021-SE-01
Project implementation time: 01.11.2022 -30.10.2026
Project coordinator: Universita Degli Studi di Padova, Italy
Research manager in Latvia: Dr. Maksym Pogorielov (Advanced Biomaterials and Biophysics Laboratory)
Project funding (University of Latvia share): 230 000 EUR
Project manager:

Summary:

MXenes are a new family of recently discovered 2D transition metal carbides, carbonitrides, and nitrides. The immune characterisation of the new materials on the basis of their physical-chemical and immunological properties will open up perspectives for the development of new therapeutic applications of nanomaterials in tissue engineering, cancer therapy, as antibacterial agents, and as immunomodulators.

The MX-MAP project will develop key strategies for MXene medical applications. The long-term goal of MX-MAP is to create a pipeline using new MXene nanomaterials for the qualitative and quantitative assessment of immunological compatibility in biomedical applications. This international research/training programme aims to support the career development of young researchers with an interdisciplinary vision of science.